Rapid elevation of serum neuron specific enolase (NSE), pro-gastrin-releasing peptidpro-GRP (pro-GRP), and disease stage are recommended as tumor markers and risk factors for early prediction of adenocarcinoma transformation to SCLC (7, 22–24). This evidence concerns the gene ENO2 and small cell lung carcinoma.